A potential tumor suppressor role of PLK2 in glioblastoma
Glioblastoma (GBM) is a highly malignant brain tumor with limited treatment options. Polo‐like kinase 2 (PLK2), a member of the polo‐like kinase family, has been variably implicated in cancer, but its role in GBM has not been fully elucidated. We utilized RNA‐seq data from multiple databases, includ...
Saved in:
| Main Authors: | Xiangping Xia, Peirui Wang, Hua Xiao, Qishan Ran, Yan Li, Shengtao Yao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | FEBS Open Bio |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/2211-5463.70000 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dissecting PTPN7‐driven aggressiveness in IDH‐wildtype astrocytomas: multi‐omics, clinical validation, and spatial transcriptomics for prognostic insights
by: Tung Liu, et al.
Published: (2025-05-01) -
Discovery of novel dual-targeting inhibitors against PLK1-PBD and PLK4-PB3: structure-guided pharmacophore modelling, virtual screening, molecular docking, molecular dynamics simulation, and biological evaluation
by: Changhao Zhao, et al.
Published: (2025-12-01) -
High-throughput virtual screening, identification and in vitro biological evaluation of novel inhibitors of PLK1 and NRP1
by: Yang Xia, et al.
Published: (2025-12-01) -
Discovery of a novel PLK1 inhibitor with high inhibitory potency using a combined virtual screening strategy
by: Zhen Xu, et al.
Published: (2025-12-01) -
Potential role of TNFRSF12A in linking glioblastoma and alzheimer’s disease via shared tumour suppressor pathways
by: Ting Liu, et al.
Published: (2025-07-01)